Status:
COMPLETED
Auto-titrating Oxygen in Chronic Respiratory Failure
Lead Sponsor:
Imperial College London
Conditions:
Chronic Obstructive Pulmonary Disease
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Long term oxygen therapy (LTOT) increases the life span of patients with chronic obstructive pulmonary disease who have low oxygen levels. However, even when on oxygen therapy at home, from time to ti...
Detailed Description
For patients with chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), disease progression leads to hypoxic respiratory failure necessitating the use of long-term oxyg...
Eligibility Criteria
Inclusion
- COPD and on LTOT
- IPF on LTOT or ambulatory oxgen
Exclusion
- Unable to mobilise for a 6 minute walk test
- Unable to consent to study,
- Partial pressure of oxygen \< 6.0 kilopascals (kPa) or Partial pressure of carbon dioxide \> 8kilopascals on air,
- Exacerbation of the underlying lung disease in the previous 4 weeks
- Unstable cardiovascular disease (e.g. arrhythmia, hypertension/hypotension or angina)
- Pregnancy
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT02248064
Start Date
July 1 2014
End Date
November 1 2015
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton and Harefield NHS Trust
London, United Kingdom, SW3 6NP